| Analysis | Metabolite Name | Measured Value | Units | Gender | Glycemic status | Neuropathy |
|---|---|---|---|---|---|---|
| C18 NEGATIVE ION MODE | FFA(18:0) | 46715394.28 | Peak area normalized | female | diabetic | Neuropathy |
| C18 NEGATIVE ION MODE | FFA(18:0) | 47549131.94 | Peak area normalized | female | normoglycemic | no neuropathy |
| C18 NEGATIVE ION MODE | FFA(18:0) | 47549436.94 | Peak area normalized | male | pre-diabetic | Neuropathy |
| C18 NEGATIVE ION MODE | FFA(18:0) | 47690925.57 | Peak area normalized | male | diabetic | Neuropathy |
| C18 NEGATIVE ION MODE | FFA(18:0) | 53907164.61 | Peak area normalized | female | diabetic | Neuropathy |
| C18 NEGATIVE ION MODE | FFA(18:0) | 54194176.37 | Peak area normalized | female | diabetic | no neuropathy |
| C18 NEGATIVE ION MODE | FFA(18:0) | 56546108.1 | Peak area normalized | female | diabetic | no neuropathy |
| C18 NEGATIVE ION MODE | FFA(18:0) | 62436700.05 | Peak area normalized | female | diabetic | Neuropathy |
| C18 NEGATIVE ION MODE | FFA(18:0) | 63957074.14 | Peak area normalized | female | normoglycemic | Neuropathy |
| C18 NEGATIVE ION MODE | FFA(18:0) | 66478833.72 | Peak area normalized | male | diabetic | no neuropathy |
| C18 NEGATIVE ION MODE | FFA(18:0) | 67275972.44 | Peak area normalized | male | pre-diabetic | no neuropathy |
| C18 NEGATIVE ION MODE | FFA(18:0) | 67550138.05 | Peak area normalized | female | diabetic | no neuropathy |
| C18 NEGATIVE ION MODE | FFA(18:0) | 90520604.75 | Peak area normalized | female | diabetic | no neuropathy |
| C18 NEGATIVE ION MODE | FFA(18:0) | 111689088.4 | Peak area normalized | female | diabetic | Neuropathy |
| Reversed phase NEGATIVE ION MODE | STEARIC ACID (M-H)- | 12094 | Peak area normalized | male | diabetic | no neuropathy |
| Reversed phase NEGATIVE ION MODE | STEARIC ACID (M-H)- | 15913 | Peak area normalized | female | diabetic | Neuropathy |
| Reversed phase NEGATIVE ION MODE | STEARIC ACID (M-H)- | 22675 | Peak area normalized | male | diabetic | Neuropathy |
| Reversed phase NEGATIVE ION MODE | STEARIC ACID (M-H)- | 23395 | Peak area normalized | female | diabetic | Neuropathy |
| Reversed phase NEGATIVE ION MODE | STEARIC ACID (M-H)- | 23998 | Peak area normalized | female | diabetic | Neuropathy |
| Reversed phase NEGATIVE ION MODE | STEARIC ACID (M-H)- | 56284 | Peak area normalized | female | normoglycemic | no neuropathy |
| Reversed phase NEGATIVE ION MODE | STEARIC ACID (M-H)- | 60934 | Peak area normalized | female | diabetic | no neuropathy |
| Reversed phase NEGATIVE ION MODE | STEARIC ACID (M-H)- | 63785 | Peak area normalized | female | diabetic | no neuropathy |
| Reversed phase NEGATIVE ION MODE | STEARIC ACID (M-H)- | 132257 | Peak area normalized | female | diabetic | no neuropathy |
| Reversed phase NEGATIVE ION MODE | STEARIC ACID (M-H)- | 184770 | Peak area normalized | female | diabetic | Neuropathy |
| Reversed phase NEGATIVE ION MODE | STEARIC ACID (M-H)- | 221712 | Peak area normalized | male | pre-diabetic | no neuropathy |
| Reversed phase NEGATIVE ION MODE | STEARIC ACID (M-H)- | 537921 | Peak area normalized | male | pre-diabetic | Neuropathy |
| Reversed phase NEGATIVE ION MODE | STEARIC ACID (M-H)- | 638477 | Peak area normalized | female | diabetic | no neuropathy |
| Reversed phase NEGATIVE ION MODE | STEARIC ACID (M-H)- | 761736 | Peak area normalized | female | normoglycemic | Neuropathy |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|